Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?

Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?

Submitted by admin on August 1, 2021 - 11:50pm
Source: 
Motley Fool
News Tags: 
Merck
Pfizer
vaccines
Vaxneuvance
Prevnar 20
pneumococcal disease
Headline: 
Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?
snippet: 
  • Merck and Pfizer are poised to go head-to-head in a vaccine market that Pfizer has dominated for a while.
  • Pfizer has a new vaccine that should enable it to prevail over Merck in the adult market.
  • But Merck has a head start over Pfizer in the large pediatric vaccine market.

Do Not Allow Advertisers to Use My Personal information